Clinical trial · Observational
A Study of ApricityRx™ for Management of IR-AEs in Patients on Immuno-Oncology Therapy
A Study of ApricityRx™ Digital Therapeutic for Management of Immune-Related Adverse Events in Patients on Immuno-Oncology Therapy
NCT04571398CI-TRIAL-00047452unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Study of ApricityRx™ for Management of IR-AEs for patients on I-O therapy. Patients currently receiving immunotherapy will be asked to consent to participate in ApricityRx software platform mobile telephone application to report symptoms, view educational content in video form about IO and irAEs and communicate with site study team.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ApricityRx mobile application | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Evaluate digital therapeutic mobile app to capture and transmit to care team patient-generated health data and access education content on IO and irAEs
- timeFrame
- 12 weeks
- description
- Number of times and percentage of study participants who use the app to report patient reported health data during a 12 week period and access education videos.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Confirmed cancer diagnosis * Prescribed treatment with immune-checkpoint inhibitor * Age ≥ 18 years * Ability to understand and the willingness to sign a written informed consent document. Exclusion Criteria: * Uncomfortable with or unwilling to use digital or mobile technology * Lack of a smart phone with compatible operating systems: iOS version 10 and above, or Android 6.0 Marshmallow * Presence of any medical, psychological or social condition that, in the opinion of the investigator, would preclude participation in this study.
References
Publications (0)
Data not yet available
No reference posted for this study.